News
Find out what’s hitting the headlines in our pioneering dementia research and how your support is bringing us closer to a cure.
If you have a press enquiry please visit our Press Office page.
- All
- Archive
- Celebrity news
- Fundraising news
- Policy news
- Science news
Air pollution linked with brain shrinkage in older women
New research published today (Wednesday 18 November) in Neurology suggests women living in areas of high pollution in the US are at increased risk of brain shrinkage. What the researchers did The researchers looked at women free of dementia at the start of the study. The scientists worked out the levels of particulate matter –…
Alzheimer’s Disease Data Initiative launches new AD Workbench to foster greater global research innovation and accelerate breakthroughs in Alzheimer’s disease and related dementias
Platform gives scientists open access to more data and new tools SEATTLE (November 17, 2020) – Launching today is the Alzheimer’s Disease Data Initiative (ADDI) and its Alzheimer’s disease (AD) Workbench, a cloud-based platform for scientists to accelerate discoveries and innovations for AD and related dementias. ADDI is a new global effort that aims to…
Expert clinicians call for new consensus on Mild Cognitive Impairment
Top clinicians and dementia experts from the NHS, universities, pharmaceutical organisations and charities have today (Tuesday 17 November) published their consensus on Mild Cognitive Impairment (MCI). The University of Manchester and Greater Manchester Health and Social Care Partnership, through its Dementia United programme, spearheaded the review, which calls for a fresh focus on how MCI…
Alzheimer’s Research UK partners with global leaders including Bill Gates to revolutionise detection of neurodegenerative diseases
Alzheimer’s Research UK, the UK’s leading dementia research charity, has partnered with global leaders, including Bill Gates, to advance the charity’s Early Detection of Neurodegenerative diseases (EDoN) initiative. The global initiative, which aims to develop a digital device to radically improve the detection of diseases that cause dementia, aims to secure at least £67million over…
Changes to how new drugs are assessed could help dementia treatments get to people sooner
Alzheimer’s Research UK says proposed changes to the way new treatments are assessed could give the dementia drugs of the future ‘a better chance of getting to the people who need them’. NICE has today (6 November) launched a public consultation that sets out the case for change to the methods it uses to develop…
Working women are at reduced risk of memory decline later in life
New US research published today (Wednesday 4 November) in Neurology suggests women at work are at a reduced risk of worsening memory. What did our expert say? Dr Rosa Sancho, Head of Research at Alzheimer’s Research UK, said: “An estimated 850,000 people in the UK have dementia and 500,000 of them are women. This research…
Cost of dementia for hospitals in England doubles in a decade
Alzheimer’s Research UK reveals the impact of dementia on hospitals in England, with a new interactive tool. The findings show that dementia cost hospitals £2.7bn in 2017/18, compared to £1.2bn in 2010/11. The charity is calling on government to deliver on its promise to double dementia research funding, to ultimately alleviate pressures on the system.…
Sir Bobby Charlton diagnosed with dementia
World Cup winner Sir Bobby Charlton has been diagnosed with dementia. Sir Bobby’s wife, Lady Norma Charlton, confirmed to The Telegraph that the former footballer has been diagnosed with dementia. Sir Bobby is famous for being part of the England World Cup winning team in 1966 and he was the top goal scorer for Manchester…
Potential Alzheimer’s treatment to be reviewed ‘within a year’ for use in EU
Today (Friday 30 October 2020) the European Medicines Agency (EMA) accepted Biogen’s application to review a potential Alzheimer’s drug, aducanumab for use in the EU. The drug will need to be approved by regulators before it could be offered more widely to the general population. What is aducanumab? Aducanumab is an antibody designed to target…
Research finds no link between hobbies and dementia risk
Research published today (Wednesday 28 October) in the scientific publication Neurology suggests those who lack interest in the world around them are at an increased risk of developing dementia. Which group of people did researchers look at? The scientists looked at a group of research volunteers taking part in an existing study. The Whitehall II…
